Cargando…
Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data
BACKGROUND: HIV-1 drug resistance can be measured with phenotypic drug-resistance tests. However, the output of these tests, the resistance factor (RF), requires interpretation with respect to the in vivo activity of the tested variant. Specifically, the dynamic range of the RF for each drug has to...
Autores principales: | Pironti, Alejandro, Walter, Hauke, Pfeifer, Nico, Knops, Elena, Lübke, Nadine, Büch, Joachim, Di Giambenedetto, Simona, Kaiser, Rolf, Lengauer, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351752/ https://www.ncbi.nlm.nih.gov/pubmed/27787339 http://dx.doi.org/10.1097/QAI.0000000000001198 |
Ejemplares similares
-
Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences
por: Pironti, Alejandro, et al.
Publicado: (2014) -
geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data
por: Döring, Matthias, et al.
Publicado: (2018) -
Using drug exposure for predicting drug resistance – A data-driven genotypic interpretation tool
por: Pironti, Alejandro, et al.
Publicado: (2017) -
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support
por: Döring, Matthias, et al.
Publicado: (2016) -
Association Between HIV-1 Coreceptor Usage and Resistance to Broadly Neutralizing Antibodies
por: Pfeifer, Nico, et al.
Publicado: (2014)